Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.
The histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet k...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
_version_ | 1797103689966551040 |
---|---|
author | Bowers, E Yan, G Mukherjee, C Orry, A Wang, L Holbert, M Crump, N Hazzalin, C Liszczak, G Yuan, H Larocca, C Saldanha, SA Abagyan, R Sun, Y Meyers, D Marmorstein, R Mahadevan, L Alani, R Cole, P |
author_facet | Bowers, E Yan, G Mukherjee, C Orry, A Wang, L Holbert, M Crump, N Hazzalin, C Liszczak, G Yuan, H Larocca, C Saldanha, SA Abagyan, R Sun, Y Meyers, D Marmorstein, R Mahadevan, L Alani, R Cole, P |
author_sort | Bowers, E |
collection | OXFORD |
description | The histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet known. Here we use a structure-based, in silico screening approach to identify a commercially available pyrazolone-containing small molecule p300 HAT inhibitor, C646. C646 is a competitive p300 inhibitor with a K(i) of 400 nM and is selective versus other acetyltransferases. Studies on site-directed p300 HAT mutants and synthetic modifications of C646 confirm the importance of predicted interactions in conferring potency. Inhibition of histone acetylation and cell growth by C646 in cells validate its utility as a pharmacologic probe and suggest that p300/CBP HAT is a worthy anticancer target. |
first_indexed | 2024-03-07T06:23:41Z |
format | Journal article |
id | oxford-uuid:f388caf1-a708-46d0-b8b7-937d5f6b6b86 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T06:23:41Z |
publishDate | 2010 |
record_format | dspace |
spelling | oxford-uuid:f388caf1-a708-46d0-b8b7-937d5f6b6b862022-03-27T12:12:56ZVirtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f388caf1-a708-46d0-b8b7-937d5f6b6b86EnglishSymplectic Elements at Oxford2010Bowers, EYan, GMukherjee, COrry, AWang, LHolbert, MCrump, NHazzalin, CLiszczak, GYuan, HLarocca, CSaldanha, SAAbagyan, RSun, YMeyers, DMarmorstein, RMahadevan, LAlani, RCole, PThe histone acetyltransferase (HAT) p300/CBP is a transcriptional coactivator implicated in many gene regulatory pathways and protein acetylation events. Although p300 inhibitors have been reported, a potent, selective, and readily available active-site-directed small molecule inhibitor is not yet known. Here we use a structure-based, in silico screening approach to identify a commercially available pyrazolone-containing small molecule p300 HAT inhibitor, C646. C646 is a competitive p300 inhibitor with a K(i) of 400 nM and is selective versus other acetyltransferases. Studies on site-directed p300 HAT mutants and synthetic modifications of C646 confirm the importance of predicted interactions in conferring potency. Inhibition of histone acetylation and cell growth by C646 in cells validate its utility as a pharmacologic probe and suggest that p300/CBP HAT is a worthy anticancer target. |
spellingShingle | Bowers, E Yan, G Mukherjee, C Orry, A Wang, L Holbert, M Crump, N Hazzalin, C Liszczak, G Yuan, H Larocca, C Saldanha, SA Abagyan, R Sun, Y Meyers, D Marmorstein, R Mahadevan, L Alani, R Cole, P Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title | Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title_full | Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title_fullStr | Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title_full_unstemmed | Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title_short | Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor. |
title_sort | virtual ligand screening of the p300 cbp histone acetyltransferase identification of a selective small molecule inhibitor |
work_keys_str_mv | AT bowerse virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT yang virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT mukherjeec virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT orrya virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT wangl virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT holbertm virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT crumpn virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT hazzalinc virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT liszczakg virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT yuanh virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT laroccac virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT saldanhasa virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT abagyanr virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT suny virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT meyersd virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT marmorsteinr virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT mahadevanl virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT alanir virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor AT colep virtualligandscreeningofthep300cbphistoneacetyltransferaseidentificationofaselectivesmallmoleculeinhibitor |